C

Center for Emotional Fitness | Cherry Hill, NJ

Research site

(Unclaimed)

Location

1 Utah Avenue, Cherry Hill, New Jersey, United States of America

Site insights

Top conditions

Top treatments

Dasotraline

SPD489

Azetukalner

Cariprazine

Lisdexamfetamine dimesylate

Troriluzole

Rapastinel

BI 1358894

Brexpiprazole

Centanafadine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 66 total trials

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) (X-CEED)

X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of azetukalner in adult part...

Enrolling

Bipolar II Disorder

Bipolar I Disorder

Drug: Placebo

Drug: Azetukalner

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of...

Enrolling

Major Depressive Disorder

Drug: Azetukalner

Drug: Placebo

A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation

The primary purpose of this study is to evaluate the efficacy of centanafadine once daily (QD) extended-release (XR) capsules in adults with attentio...

Enrolling

Attention-deficit/Hyperactivity Disorder

Emotional Dysregulation

Drug: Centanafadine XR

An Open-Label Study of Azetukalner in Major Depressive Disorder (X-NOVA-OLE)

X-NOVA-OLE is a multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner as a monotherapy in adult p...

Invitation-only

Major Depressive Disorder

Drug: Azetukalner